Moderna, Inc. (MRNA) Financials

MRNA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 18.4 billion 4.6 billion
2023-09-30 19.5 billion 6.0 billion
2023-06-30 21.9 billion 4.9 billion
2023-03-31 24.1 billion 5.3 billion

MRNA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 402.0 million 79.0 million
2023-09-30 -1.7 billion 77.0 million
2023-06-30 -1.1 billion 74.0 million
2023-03-31 -1.3 billion 75.0 million

MRNA Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 217.0 million
2023-09-30 -3.6 billion
2023-06-30 -1.4 billion
2023-03-31 79.0 million

MRNA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 8.6 billion - 1.2 billion
2023-09-30 7.6 billion - 1.3 billion
2023-06-30 8.5 billion - 947.0 million
2023-03-31 8.9 billion - 927.0 million

MRNA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 395.0 million
2023-09-30 381.0 million
2023-06-30 381.0 million
2023-03-31 405.0 million

MRNA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 220.0 million 1.4 billion 470.0 million -
2023-09-30 140.0 million 1.2 billion 442.0 million -
2023-06-30 234.0 million 1.1 billion 332.0 million -
2023-03-31 113.0 million 1.1 billion 305.0 million -

MRNA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.8 billion 929.0 million
2023-09-30 1.8 billion 2.2 billion
2023-06-30 344.0 million 731.0 million
2023-03-31 1.9 billion 792.0 million

MRNA

Price: $125.59

52 week price:
62.55
163.24

Earnings Per Share: -12.33 USD

P/E Ratio: -10.56

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 3.3 million

Market Capitalization: 42.1 billion

Links: